No black box warning on record for Ahzantive

As of the latest FDA labeling reviewed, Ahzantive (AFLIBERCEPT-MRBB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ahzantive medicine page for the complete safety profile.

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS 5.1 Endophthalmitis, Retinal Detachments, and Retinal Vasculitis with or without Occlusion Intravitreal injections, including those with aflibercept products, have been associated with endophthalmitis and retinal detachments [see Adverse Reactions (6.1)] and, more rarely, retinal vasculitis with or without occlusion [see Adverse Reactions (6.2)]. Proper aseptic injectio

No black box warning on record for Ahzantive

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS 5.1 Endophthalmitis, Retinal Detachments, and Retinal Vasculitis with or without Occlusion Intravitreal injections, including those with aflibercept products, have been associated with endophthalmitis and retinal detachments [see Adverse Reactions (6.1)] and, more rarely, retinal vasculitis with or without occlusion [see Adverse Reactions (6.2)]. Proper aseptic injectio

Ahzantive Black Box Warning

No black box warning on record for Ahzantive

Other warnings & precautions

Ahzantive Black Box Warning

No black box warning on record for Ahzantive

Other warnings & precautions